QRICH1 and acute lymphoblastic leukemia: In fact, ERS-induced T-ALL cells overexpressing QRICH1 exhibited a significant synergistic effect (Supplementary Fig. 2A, B), which may be a vital clue for reversing chemotherapy resistance.